Related Experiment Video
Updated: Feb 15, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM
Xiangrong Chen1, Shun Li2, Yumin Ke3
1a Department of Neurosurgery , The Second Affiliated Hospital, Fujian Medical University , Quanzhou , PR China.
Background:
This study aims to via unveiling the novel mechanisms of KLF16 in regulating expression of genes involved in glioma.
Methods:
KLF16 or KLF16-siRNA was transfected to U87MG cells by lentivirus. Colony formation assay was applied for detecting cell proliferation. MTT assay was adopted to assess cell viability. TUNEL assay was selected to evaluate cell apoptosis. Flow cytometry was used to determine cell cycle. Real-time PCR was performed to test mRNA expression. Western blot was used to detect protein level. Luciferase assay was applied to confirm the regulatory relationship between KLF16 and Mitochondrial transcription factor A (TFAM). Chromatin immunoprecipitation was adopted to test the protein binding site. The nude mouse transplantation tumour experiment was selected to test cancer cell proliferation in vivo.
Results:
KLF16 was decreased in glioma cells and tissues. KLF16 obviously restrained U87MG cell proliferation both in vivo and in vitro. KLF16 transfection reduced mRNA and protein levels related to cell proliferation. KLF16 targeted a putative binding site near the transcription start sites (TSSs) of TFAM gene, thus suppressing glioma cell proliferation. KLF16-siRNA exhibited the opposite impact. KLF16 presented significant negative correlation with TFAM level in glioma patients.
Conclusions:
KLF16 is a key regulator of glioma cell proliferation by directly targeting TFAM.
Insights
Krüppel-like factor 16 (KLF16) suppresses glioma cell proliferation by targeting Mitochondrial transcription factor A (TFAM). Reduced KLF16 levels correlate with increased tumor growth, highlighting KLF16 as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Glioma is a complex brain tumor with poorly understood regulatory mechanisms.
- Identifying novel regulators of glioma cell proliferation is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of Krüppel-like factor 16 (KLF16) in regulating gene expression within glioma.
- To elucidate the specific mechanisms by which KLF16 influences glioma cell proliferation.
Main Methods:
- Utilized lentiviral transfection of KLF16 or KLF16-siRNA in U87MG cells.
- Assessed cell proliferation, viability, apoptosis, and cell cycle using colony formation, MTT, TUNEL, and flow cytometry assays.
- Confirmed the direct regulatory relationship between KLF16 and Mitochondrial transcription factor A (TFAM) via luciferase and chromatin immunoprecipitation assays.
Main Results:
- KLF16 expression was significantly decreased in glioma cells and tissues.
- KLF16 overexpression suppressed glioma cell proliferation both in vitro and in vivo.
- KLF16 directly targeted the TFAM gene promoter, inhibiting TFAM expression and downstream proliferation pathways.
Conclusions:
- KLF16 acts as a tumor suppressor in glioma by directly inhibiting TFAM.
- KLF16 represents a promising therapeutic target for glioma treatment.
More Related Videos
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Related Concept Videos
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Targeted Cancer Therapies
There are several types of targeted therapies against...